Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (317) 317
Publication (31) 31
Book Review (5) 5
Newsletter (3) 3
Magazine Article (2) 2
Book / eBook (1) 1
Book Chapter (1) 1
Conference Proceeding (1) 1
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (191) 191
infectious diseases (119) 119
male (103) 103
index medicus (99) 99
adult (98) 98
immunology (93) 93
female (90) 90
hiv (83) 83
hiv infections - drug therapy (83) 83
virology (60) 60
hiv infections - immunology (58) 58
cd4 lymphocyte count (51) 51
aids (42) 42
hiv infections - virology (42) 42
viral load (40) 40
middle aged (38) 38
antiretroviral therapy (37) 37
human immunodeficiency virus--hiv (37) 37
anti-hiv agents - therapeutic use (36) 36
cohort studies (35) 35
research (34) 34
infection (33) 33
aids/hiv (32) 32
hiv infection (32) 32
infections (32) 32
antiretroviral therapy, highly active (30) 30
prevalence (27) 27
antiviral agents (25) 25
care and treatment (25) 25
diagnosis (25) 25
hiv infections - epidemiology (25) 25
risk factors (25) 25
active antiretroviral therapy (24) 24
drug therapy (24) 24
hiv-1 (24) 24
disease progression (23) 23
human-immunodeficiency-virus (23) 23
acquired immune deficiency syndrome--aids (22) 22
adolescent (22) 22
hepatitis (21) 21
hiv infections - complications (21) 21
hiv-1 - genetics (21) 21
hiv-1 - immunology (21) 21
microbiology (21) 21
hepatitis b (20) 20
hepatitis c (19) 19
highly active antiretroviral therapy (19) 19
medical research (19) 19
usage (19) 19
aged (18) 18
anti-retroviral agents - therapeutic use (18) 18
health aspects (18) 18
hepatitis c - diagnosis (18) 18
antiretroviral drugs (17) 17
epidemiology (17) 17
mortality (17) 17
public, environmental & occupational health (17) 17
studies (17) 17
treatment outcome (17) 17
child (16) 16
cohort (16) 16
hepatitis b virus (16) 16
infectious and parasitic diseases (16) 16
therapy (16) 16
adults (15) 15
amino acid sequence (15) 15
cd8-positive t-lymphocytes - immunology (15) 15
hiv/aids (15) 15
time factors (15) 15
virus diseases (15) 15
world health organization (15) 15
genotype (14) 14
hepatitis c virus (14) 14
individuals (14) 14
antigens (13) 13
global health (13) 13
hiv-1 - drug effects (13) 13
molecular sequence data (13) 13
reverse transcriptase inhibitors - therapeutic use (13) 13
risk-factors (13) 13
survival (13) 13
united kingdom (13) 13
viruses (13) 13
africa (12) 12
analysis (12) 12
article (12) 12
disease (12) 12
drug therapy, combination (12) 12
hepatitis b - diagnosis (12) 12
hiv-1 - physiology (12) 12
human immunodeficiency virus (12) 12
medicine, general & internal (12) 12
retrospective studies (12) 12
treatment failure (12) 12
tuberculosis (12) 12
hiv patients (11) 11
immunodeficiency-virus type-1 (11) 11
incidence (11) 11
infected patients (11) 11
mutation (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Bringing to an end mother-to-child transmission of hepatitis B: A role for quantitative hepatitis B surface antigen?
: Dusheiko and Easterbrook
by Dusheiko, Geoffrey and Easterbrook, Philippa
Hepatology, ISSN 0270-9139, 11/2016, Volume 64, Issue 5, pp. 1408 - 1410
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Efavirenz: A Viewpoint by Philippa J. Easterbrook
by Easterbrook P.J
Drugs, ISSN 0012-6667, 12/1998, Volume 56, Issue 6, pp. 1065 - 1066
HIV-1-infections, treatment | Non-nucleoside-reverse-transcriptase-inhibitors, g | New-drug-profiles | Antivirals, general | Efavirenz, general
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Incidence and Risk Factors for Immune Reconstitution Inflammatory Syndrome in an Ethnically Diverse HIV Type 1-Infected Cohort
by I. Ratnam and C. Chiu and N.-B. Kandala and P. J. Easterbrook
Clinical Infectious Diseases, ISSN 1058-4838, 2/2006, Volume 42, Issue 3, pp. 418 - 427
Background. It is estimated that 10%-25% of patients who start highly active antiretroviral therapy (HAART) experience immune reconstitution inflammatory... 
HIV/AIDS | Highly active antiretroviral therapy | Herpes zoster | Simplexvirus | Percentages | HIV | Mycobacterium tuberculosis | Condylomata acuminata | AIDS | Infections | Hepatitis B | RESPONSES | INFECTIOUS DISEASES | INITIATION | ACTIVE ANTIRETROVIRAL THERAPY | HERPES-ZOSTER | OPPORTUNISTIC INFECTIONS | MICROBIOLOGY | RESTORATION DISEASE | IMMUNOLOGY | Inflammation - chemically induced | Inflammation - pathology | Humans | Male | Incidence | Reverse Transcriptase Inhibitors - adverse effects | HIV Infections - immunology | CD4-CD8 Ratio | Adult | Anti-HIV Agents - therapeutic use | Female | Retrospective Studies | Reverse Transcriptase Inhibitors - therapeutic use | Immune Tolerance - drug effects | Anti-HIV Agents - adverse effects | Risk Factors | European Continental Ancestry Group | Syndrome | Antiretroviral Therapy, Highly Active | Asian Continental Ancestry Group | HIV Infections - complications | HIV Infections - drug therapy | African Continental Ancestry Group | HIV Infections - ethnology | Cohort Studies | Immune recognition | Inflammatory bowel diseases | Care and treatment | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
by Platt, Lucy, Dr and Easterbrook, Philippa, MD and Gower, Erin, MPH and McDonald, Bethan, PhD and Sabin, Keith, PhD and McGowan, Catherine, PhD and Yanny, Irini, MBChB and Razavi, Homie, PhD and Vickerman, Peter, Prof
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 7, pp. 797 - 808
Summary Background At global level, there are 37 million people infected with HIV and 115 million people with antibodies to hepatitis C virus (HCV). Little is... 
Infectious Disease | INFECTIOUS DISEASES | INFECTIONS | SUB-SAHARAN AFRICA | HEPATITIS-C-VIRUS | BLOOD-DONORS | INJECTING DRUG-USERS | VIRAL-HEPATITIS | SEROPREVALENCE | EPIDEMIOLOGY | CARE | Hepacivirus - isolation & purification | Prevalence | Global Health | HIV Infections - epidemiology | Hepatitis C - epidemiology | Humans | Coinfection - epidemiology | Hepatitis C virus | HIV (Viruses) | Hepatitis C | Health aspects | Epidemiology | Analysis | Medical research | Medicine, Experimental | HIV infection | Studies | Antiretroviral drugs | Hepatitis | Surveillance | Human immunodeficiency virus--HIV | Mortality | Population | Infections | Estimates | Public health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Who to test and how to test for chronic hepatitis C infection – 2016 WHO testing guidance for low- and middle-income countries
by Easterbrook, Philippa J and WHO Guidelines Dev Grp and WHO Guidelines Development Group
Journal of Hepatology, ISSN 0168-8278, 2016, Volume 65, Issue 1, pp. S46 - S66
Summary Testing and diagnosis of hepatitis C virus (HCV) infection is the gateway for access to both treatment and prevention services, and crucial for an... 
Gastroenterology and Hepatology | Focused testing | Rapid diagnostic tests (RDTs) | Dried blood spots (DBS) | Birth cohort | Hepatitis C | General population testing | Testing | COST-EFFECTIVENESS | RAPID TEST | INJECTING DRUG-USERS | HUMAN-IMMUNODEFICIENCY-VIRUS | REAL-TIME PCR | HCV-RNA | DRIED BLOOD SPOT | PERFORMANCE-CHARACTERISTICS | GASTROENTEROLOGY & HEPATOLOGY | ANTIBODY DETECTION | VIRUS CORE ANTIGEN | World Health Organization | Global Health | Humans | Risk Factors | Male | Hepatitis B, Chronic - diagnosis | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Virology - methods | Developed Countries | Female | Developing Countries | Hepatitis C, Chronic - epidemiology | Virus diseases | HIV testing | Diagnosis | Hepatitis C virus | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. MCQs in basic medical sciences for MRCP part 1
by Easterbrook, Philippa and Mokbel, K. M. (Kefah M)
1996, 1st. ed., ISBN 9780906896341, 170
Examinations, questions, etc | Medical sciences
Book
Details down arrow
7. Full Text Systematic review of the empirical evidence of study publication bias and outcome reporting bias
by Dwan, Kerry and Altman, Douglas G and Arnaiz, Juan A and Bloom, Jill and Chan, An-Wen and Cronin, Eugenia and Decullier, Evelyne and Easterbrook, Philippa J and Von Elm, Erik and Gamble, Carrol and Ghersi, Davina and Ioannidis, John P.A and Simes, John and Williamson, Paula R
PLoS ONE, ISSN 1932-6203, 08/2008, Volume 3, Issue 8, p. e3081
Background: The increased use of meta-analysis in systematic reviews of healthcare interventions has highlighted several types of bias that can arise during... 
RESEARCH ETHICS COMMITTEE | BIOMEDICAL-RESEARCH | RANDOMIZED-TRIALS | CUMULATIVE METAANALYSES | MULTIDISCIPLINARY SCIENCES | CLINICAL-TRIALS | RETROSPECTIVE COHORT | HEALTH-RESEARCH | SELECTION BIAS | FOLLOW-UP | TIME | Publishing | Humans | Publication Bias | Treatment Outcome | Clinical Trials as Topic | Cohort Studies | Patient Selection | Randomized Controlled Trials as Topic | Decision-making | Usage | Discrimination in medical care | Analysis | Health care | Medical research | Statistical analysis | Decision making | Bias | Clinical trials | Decision analysis | Reporting | Empirical analysis | Studies | Literature reviews | Randomization | Reviews | Documents | Significance | Assaigs clínics | Biaix de publicació | Publication bias
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions
by Haddow, Lewis J, PhD and Colebunders, Robert, Prof and Meintjes, Graeme, MBChB and Lawn, Stephen D, MD and Elliott, Julian H, PhD and Manabe, Yukari C, MD and Bohjanen, Paul R, Prof and Sungkanuparph, Somnuek, MD and Easterbrook, Philippa J, FRCP and French, Martyn A, Prof and Boulware, David R, Dr and Int Network Study HIV-Associated and International Network for the Study of HIV-associated IRIS (INSHI)
Lancet Infectious Diseases, The, ISSN 1473-3099, 2010, Volume 10, Issue 11, pp. 791 - 802
Summary Cryptococcal immune reconstitution inflammatory syndrome (IRIS) may present as a clinical worsening or new presentation of cryptococcal disease after... 
Infectious Disease | ACQUIRED-IMMUNODEFICIENCY-SYNDROME | HIGH-DOSE FLUCONAZOLE | SOUTH-AFRICA | INFECTIOUS DISEASES | RISK-FACTORS | INCREASED INTRACRANIAL-PRESSURE | ACTIVE ANTIRETROVIRAL THERAPY | OPPORTUNISTIC INFECTIONS | AMPHOTERICIN-B | NEOFORMANS INFECTION | HIV-INFECTED PATIENTS | Immune Reconstitution Inflammatory Syndrome - microbiology | Cryptococcosis - pathology | Cryptococcosis - microbiology | Immune Reconstitution Inflammatory Syndrome - diagnosis | Anti-HIV Agents - adverse effects | HIV Infections - virology | Humans | Anti-HIV Agents - administration & dosage | Immune Reconstitution Inflammatory Syndrome - pathology | HIV-1 - isolation & purification | Cryptococcus - immunology | Cryptococcus - isolation & purification | HIV Infections - complications | Cryptococcosis - diagnosis | HIV Infections - drug therapy | HIV (Viruses) | HIV patients | HIV infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries
by Loyse, Angela, MRes and Thangaraj, Harry, MBBS and Easterbrook, Philippa, Prof and Ford, Nathan, PhD and Roy, Monika, MD and Chiller, Tom, MD and Govender, Nelesh, MBBCh and Harrison, Thomas S, Prof and Bicanic, Tihana, BM BCh
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 7, pp. 629 - 637
Summary Cryptococcal meningitis is the leading cause of adult meningitis in sub-Saharan Africa, and contributes up to 20% of AIDS-related mortality in... 
Infectious Disease | HIGH-DOSE FLUCONAZOLE | TRIAL | INFECTIOUS DISEASES | FLUCYTOSINE | EARLY FUNGICIDAL ACTIVITY | SURVEILLANCE | COMBINATION | FORMULATION | VISCERAL LEISHMANIASIS | LIPOSOMAL AMPHOTERICIN-B | HIV-INFECTED PATIENTS | Meningitis, Cryptococcal - drug therapy | AIDS-Related Opportunistic Infections - epidemiology | Humans | Meningitis, Cryptococcal - epidemiology | AIDS-Related Opportunistic Infections - drug therapy | Treatment Outcome | Developing Countries | Africa South of the Sahara - epidemiology | Health Services Accessibility - trends | Antifungal Agents - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Bringing to an end mother‐to‐child transmission of hepatitis B: A role for quantitative hepatitis B surface antigen?
by Dusheiko, Geoffrey and Easterbrook, Philippa
Hepatology, ISSN 0270-9139, 11/2016, Volume 64, Issue 5, pp. 1408 - 1410
PROPHYLAXIS | VIRUS | GASTROENTEROLOGY & HEPATOLOGY | HBV | PREGNANCY | Humans | Pregnancy Complications, Infectious | Infectious Disease Transmission, Vertical | Hepatitis B Surface Antigens | Child | Hepatitis B virus - immunology | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
by Eaton, Jeffrey W, PhD and Menzies, Nicolas A, MPH and Stover, John, MA and Cambiano, Valentina, MS and Chindelevitch, Leonid, PhD and Cori, Anne, PhD and Hontelez, Jan A C, PhD and Humair, Salal, PhD and Kerr, Cliff C, PhD and Klein, Daniel J, PhD and Mishra, Sharmistha, MD and Mitchell, Kate M, PhD and Nichols, Brooke E, MS and Vickerman, Peter, Prof and Bakker, Roel, PhD and Bärnighausen, Till, DSc and Bershteyn, Anna, PhD and Bloom, David E, Prof and Boily, Marie-Claude, PhD and Chang, Stewart T, PhD and Cohen, Ted, DPH and Dodd, Peter J, PhD and Fraser, Christophe, Prof and Gopalappa, Chaitra, PhD and Lundgren, Jens, Prof and Martin, Natasha K, DPhil and Mikkelsen, Evelinn, MSc and Mountain, Elisa, MSc and Pham, Quang D, MD and Pickles, Michael, PhD and Phillips, Andrew, Prof and Platt, Lucy, PhD and Pretorius, Carel, PhD and Prudden, Holly J, MSc and Salomon, Joshua A, Prof and van de Vijver, David A M C, PhD and de Vlas, Sake J, PhD and Wagner, Bradley G, PhD and White, Richard G, PhD and Wilson, David P, PhD and Zhang, Lei, PhD and Blandford, John, PhD and Meyer-Rath, Gesine, PhD and Remme, Michelle, MSc and Revill, Paul, PhD and Sangrujee, Nalinee, PhD and Terris-Prestholt, Fern, PhD and Doherty, Meg, PhD and Shaffer, Nathan, MD and Easterbrook, Philippa J, Prof and Hirnschall, Gottfried, MD and Hallett, Timothy B, Prof
The Lancet Global Health, ISSN 2214-109X, 2014, Volume 2, Issue 1, pp. e23 - e34
Summary Background New WHO guidelines recommend initiation of antiretroviral therapy for HIV-positive adults with CD4 counts of 500 cells per μL or less, a... 
Internal Medicine | HIV/AIDS | HIV PREVENTION | SOUTH-AFRICA | IMPACT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ART | SEX | RISK | INFECTION | PREVALENCE | SETTINGS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Incidence, Clinical Spectrum, Risk Factors and Impact of HIV-Associated Immune Reconstitution Inflammatory Syndrome in South Africa
by Haddow, Lewis John and Moosa, Mahomed-Yunus Suleman and Mosam, Anisa and Moodley, Pravi and Parboosing, Raveen and Easterbrook, Philippa Jane
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e40623
Background: Immune reconstitution inflammatory syndrome (IRIS) is a widely recognised complication of antiretroviral therapy (ART), but there are still limited... 
CASE-DEFINITION | RESOURCE-LIMITED SETTINGS | SUB-SAHARAN AFRICA | CRYPTOCOCCAL ANTIGENEMIA | TUBERCULOSIS | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | HERPES-ZOSTER | INFECTED PATIENTS | RESTORATION DISEASE | EARLY MORTALITY | Immune Reconstitution Inflammatory Syndrome - etiology | AIDS-Related Opportunistic Infections | Follow-Up Studies | Humans | Risk Factors | South Africa - epidemiology | Antiretroviral Therapy, Highly Active - adverse effects | Male | CD4 Lymphocyte Count | Immune Reconstitution Inflammatory Syndrome - mortality | Immune Reconstitution Inflammatory Syndrome - epidemiology | Viral Load | Incidence | HIV Infections - complications | Adult | Female | HIV Infections - drug therapy | Infection | Fertility clinics | Highly active antiretroviral therapy | Antiviral agents | Tuberculosis | Mortality | Mycoses | Development and progression | HIV (Viruses) | Health aspects | Risk factors | Health care | Therapy | C-reactive protein | Opportunist infection | Infections | Optimization | Confidence intervals | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Hemoglobin | Occupational health | Medical personnel | Antiretroviral drugs | Herpes zoster | Immunodeficiency | Cryptococcosis | Health risks | Immune reconstitution | Inflammation | Folliculitis | Risk analysis | Patients | Morbidity | Antiretroviral therapy | Warts | Lymphadenopathy | Ulcers | Fatalities | Adults | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights